𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suramin: an anticancer drug with unique biological effects

✍ Scribed by Annette Kragh Larsen

Book ID
104886862
Publisher
Springer
Year
1993
Tongue
English
Weight
341 KB
Volume
32
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and comparative effectiveness o
Efficacy and comparative effectiveness of sirolimus as an anticancer drug
✍ Melissa Hu; Oleksandr Ekshyyan; Lilantha Herman Ferdinandez; Xiaohua Rong; Glori πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

## Abstract ## Objectives/Hypothesis: To evaluate antitumor efficacy of the generic mammalian target of rapamycin (mTOR) inhibitor sirolimus in preclinical animal models of head and neck squamous cell carcinoma (HNSCC) and compare its effects with those of the patented analogue temsirolimus. ## S

Analysis of anticancer drugs in biologic
Analysis of anticancer drugs in biological fluids: determination of taxol with application to clinical pharmacokinetics
✍ Jinee Rizzo; Christopher Riley; Daniel von Hoff; John Kuhn; Jerry Phillips; Thom πŸ“‚ Article πŸ“… 1990 πŸ› Elsevier Science 🌐 English βš– 561 KB

Taxol, a novel antimitotic, antitumor agent is currently undergoing Phase 1 clinical trials for the treatment of various tumors. An isocratic HPLC method has been developed for the determination of taxol in human plasma and urine. The method was then applied to the clinical pharmacokinetics of taxol

Phenoxodiol, an experimental anticancer
Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects
✍ Jennifer R. Gamble; Pu Xia; Christopher N. Hahn; Jenny J. Drew; Christopher J. D πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 903 KB

## Abstract Phenoxodiol (2H‐1‐benzopyran‐7‐0,1, 3‐[4‐hydroxyphenyl], PXD) is a synthetic analogue of the naturally‐occurring plant isoflavone and anticancer agent, genistein. PXD directly induces mitotic arrest and apoptosis in most cancer cells and is currently undergoing clinical trials, as a che